Sihuan Pharmaceutical Holdings Group Ltd.

0460.HK

HKSEHealthcareDrug Manufacturers - Specialty & Generic

Open in GoAI

Latest quote

HK$0.86

−HK$0.015 · -1.71%

Aug 24, 4:08 PM HKT

Regular session · HKT · Market data may be delayed.

Company profile

Company website

Sihuan Pharmaceutical Holdings Group Ltd. is an investment holding company that engages in the research, development, manufacture, and sale of pharmaceutical and medical aesthetic products. Its portfolio includes products for the cardio-cerebral vascular system, as well as segments for innovative medicine, generic medicine, and medical aesthetics which includes injectables, energy-based devices, and skincare solutions. The company operates primarily in the People's Republic of China, with some international presence.

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Headquarters: HK
CEO: Wei Cheng Guo
Listed since: Oct 28, 2010
Employees: 2,843

Market position

52-week range

Current HK$0.86

HK$0.82HK$1.92

Open: HK$0.86
Previous close: HK$0.875
Volume: 37.39M; 1.24× average
Average volume: 30.15M; Average daily volume
Market cap: 7.78B HKD
Beta: 0.87; Market reference 1
50-day average: HK$0.8852; -2.85% below average
200-day average: HK$1.2276; -29.94% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value: 7.52B CNY
P/E (TTM): 37.64×
P/B (TTM): 1.14×
P/S (TTM): 2.55×
EV / EBITDA: 11.71×
Earnings yield: 1.78%
Free cash flow yield: -2.16%
Dividend yield: 1.27%

Profitability & efficiency

Gross margin: 68.83%
Operating margin: 23.19%
Net margin: 6.86%
Return on equity: 3.07%
Return on assets: 1.54%
Return on invested capital: 3.28%

Financial health

Debt / equity: 0.17×
Current ratio: 1.8×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin

Income trends

Revenue

2.62B CNY+37.71%

Operating income

607.12M CNY+745.26M CNY

Net income

179.7M CNY+396.36M CNY

Metric (CNY)	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	2.62B CNY	1.9B CNY	1.86B CNY	2.18B CNY	3.04B CNY
Cost of goods sold	816.15M CNY	659.4M CNY	564.9M CNY	693.61M CNY	607.9M CNY
Gross profit	1.8B CNY	1.24B CNY	1.3B CNY	1.49B CNY	2.43B CNY
Research and development	327.48M CNY	504.02M CNY	592.01M CNY	1.08B CNY	868.07M CNY
Selling, general, and administrative	1.12B CNY	1.18B CNY	911.22M CNY	1.02B CNY	1.13B CNY
Operating expenses	1.19B CNY	1.38B CNY	1.13B CNY	3.32B CNY	1.66B CNY
Interest income	98.83M CNY	175.55M CNY	147.91M CNY	146.79M CNY	163.95M CNY
Interest expense	201.58M CNY	274.93M CNY	269.34M CNY	211.18M CNY	117.35M CNY
Depreciation and amortization	165.89M CNY	180.75M CNY	226.23M CNY	369.81M CNY	255.49M CNY
Operating income	607.12M CNY	−138.13M CNY	161.7M CNY	−1.83B CNY	771.95M CNY
Net income	179.7M CNY	−216.66M CNY	−54.02M CNY	−1.91B CNY	416.51M CNY